| Literature DB >> 29045846 |
Bonnie Hiener1, Bethany A Horsburgh2, John-Sebastian Eden3, Kirston Barton2, Timothy E Schlub4, Eunok Lee2, Susanne von Stockenstrom5, Lina Odevall5, Jeffrey M Milush6, Teri Liegler6, Elizabeth Sinclair6, Rebecca Hoh6, Eli A Boritz7, Daniel Douek8, Rémi Fromentin9, Nicolas Chomont9, Steven G Deeks6, Frederick M Hecht6, Sarah Palmer2.
Abstract
Latent replication-competent HIV-1 persists in individuals on long-term antiretroviral therapy (ART). We developed the Full-Length Individual Proviral Sequencing (FLIPS) assay to determine the distribution of latent replication-competent HIV-1 within memory CD4+ T cell subsets in six individuals on long-term ART. FLIPS is an efficient, high-throughput assay that amplifies and sequences near full-length (∼9 kb) HIV-1 proviral genomes and determines potential replication competency through genetic characterization. FLIPS provides a genome-scale perspective that addresses the limitations of other methods that also genetically characterize the latent reservoir. Using FLIPS, we identified 5% of proviruses as intact and potentially replication competent. Intact proviruses were unequally distributed between T cell subsets, with effector memory cells containing the largest proportion of genetically intact HIV-1 proviruses. We identified multiple identical intact proviruses, suggesting a role for cellular proliferation in the maintenance of the latent HIV-1 reservoir.Entities:
Keywords: HIV; antiretroviral therapy; cellular proliferation; clonal expansion; full-length HIV sequencing; latency; replication competency; single proviral sequencing
Mesh:
Year: 2017 PMID: 29045846 PMCID: PMC5960642 DOI: 10.1016/j.celrep.2017.09.081
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423